GENinCode
GENI · AIM · Health Care · mcap £4.9m · 0.6p
Nestor Oller Bube is reporting a first-time notification of a major holding in GENinCode PLC
3 Jun · 1 notice
10.6% → 13.8%
share price at the notices 1.2p · now 0.6p
3 Jun 2026
Philip M Chesterfield
24 Feb · 1 notice
below 3% → 9.4%
share price at the notices 1.2p · now 0.6p
24 Feb 2026
Maven Capital Partners UK LLP
8 Dec – 15 Apr · 3 notices
12.5% → 7.7%
Octopus Investments Limited
12 Feb · 1 notice
18.4% → 7.0%
share price at the notices 1.1p · now 0.6p
12 Feb 2026
First Equity Limited
12 Feb – 30 Sep · 7 notices
below 3% → 5.5%
share price at the notices 0.7–1.2p · now 0.6p
12 Feb 2026 26 Feb 2026 14 Apr 2026 8 May 2026 4 Jun 2026 11 Jun 2026 30 Sep 2026
Dowgate Group Limited
13 Oct · 1 notice
7.0% → 4.2%
share price at the notices 3.6p · now 0.6p
13 Oct 2025
Ian Amiee , Daryl Amiee and Doolittle SSAS account Amiee
10 Jun · 1 notice
3.1% → 3.1%
share price at the notices 0.9p · now 0.6p
10 Jun 2026
Directors
No open-market share purchases by directors in 12 months.
other GENinCode Plc announced that all resolutions concerning its placing, subscription, and retail offer were passed at a General Meeting, with resolutions to allot shares and disapply pre-emption rights receiving overwhelmin 9 Feb 2026
award GENinCode Plc has announced the grant of new share options to directors and employees under its 2021 Share Option Plan, totaling 83,847,292 new ordinary shares, representing 11.13% of the existing issued share capital. T 7 May 2026
Company filings. Not investment advice.